Michael Schwameis

Immunogenicity, safety, and tolerability of a recombinant measles-virus-based chikungunya vaccine: a randomised, double-blind, placebo-controlled, active-comparator, first-in-man trial

Katrin Ramsauer, Michael Schwameis, Christa Firbas et al. · The Lancet Infectious Diseases · 2015 · 233 citations

Veterinary Medicine, Immunology, Infectious Diseases +11

A randomized, placebo-controlled phase I study assessing the safety and immunogenicity of a<i>Pseudomonas aeruginosa</i>hybrid outer membrane protein OprF/I vaccine (IC43) in healthy volunteers

Kerstin Westritschnig, Romana Hochreiter, Gerhard Wallner et al. · Human Vaccines & Immunotherapeutics · 2013 · 86 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Neurological manifestations of COVID-19 in adults and children

Sung‐Min Cho, Nicole White, Lavienraj Premraj et al. · Brain · 2022 · 84 citations · Full text

Medicine, Infectious Diseases, Pediatrics +8

COVID-19 symptoms at hospital admission vary with age and sex: results from the ISARIC prospective multinational observational study

Sheryl Ann Abdukahil, Ryuzo Abe, Laurent Abel et al. · Infection · 2021 · 80 citations · Full text

Public Health, Infectious Diseases, Pediatrics +9

Morphine decreases ticagrelor concentrations but not its antiplatelet effects: a randomized trial in healthy volunteers

Eva‐Luise Hobl, Birgit Reiter, Christian Schoergenhofer et al. · European Journal of Clinical Investigation · 2015 · 73 citations

Medicine, Pharmacology, Pharmacotherapy +11